Byooviz Or Beovu? Canadian Court Halts Samsung, Biogen Biosimilar Trademark
Novartis Wins Trademark Infringement Action, Leading To Injunctive Relief
In a rather novel case in Canada, Novartis has established before a Federal district court that there is a likelihood that the trademark rights for its Beovu brand will be confused with Samsung Bioepis and Biogen’s Byooviz biosimilar.
